Indiya ta yi gwajin COVID-19, keɓewa dole ga duk 'yan Burtaniya

• Indiya ta kira matakin Birtaniyya na kin amincewa da sigar Indiya ta allurar AstraZeneca, da aka sani da Covishield, “nuna wariya”.
• 'Yan asalin Burtaniya da suka yi allurar rigakafin da suka isa Indiya za a keɓe masu keɓewa na kwanaki 10.
• Daga ranar Litinin, duk masu isowa Burtaniya za su gabatar da gwajin COVID-19 mara kyau wanda aka ɗauka aƙalla sa'o'i 72 kafin tashi.

---

A bayyane yake, jami'an Ma'aikatar Harkokin Wajen Indiya a yau sun ba da sanarwar cewa duk 'yan asalin Burtaniya, gami da waɗanda aka yi wa allurar riga-kafi, za a keɓe masu keɓewa na kwanaki 10 idan sun isa Indiya.

Da alama ana gabatar da sabon buƙatun don mayar da martani ga irin wannan matakan da Burtaniya ta dorawa 'yan kasar Indiya.

Sabuwar sanarwar manufofin na zuwa ne bayan Sakataren Harkokin Wajen Indiya Harsh Vardhan Shringla ya kira matakin Burtaniya na kin amincewa da sigar Indiya ta AstraZeneca allurar rigakafi, da aka sani da Covishield, “nuna wariya”.

Ministan ya yi gargadin daukar matakai idan London ta kasa sake yin nazari.

Tun daga ranar Litinin, duk masu zuwa Biritaniya-ba tare da la’akari da matsayin rigakafin su ba-za su gabatar da gwajin COVID-19 mara kyau da aka ɗauka aƙalla awanni 72 kafin tashi, yi gwaji na biyu kan isowa da kuma na uku bayan kwana takwas.

Hakanan za a aiwatar da lokacin keɓewa na kwanaki 10, a cewar wani jami'in ma'aikatar harkokin wajen.

Gwamnatin Burtaniya ta ba da sanarwar a watan da ya gabata cewa za ta ba da damar cikakken matafiya masu yin allurar rigakafi su tsallake keɓe masu cutarwa kuma su ɗauki ƙarancin gwaji, amma kawai an gane allurar rigakafin a ƙarƙashin shirye -shiryen Amurka, Biritaniya ko Turai ko waɗanda wata ƙungiya ta lafiya ta amince.

Fiye da dozin ƙasashe a Asiya, Caribbean da Gabas ta Tsakiya sun shiga cikin jerin, amma IndiaBa a haɗa shirin ba. Hakanan, babu wani shirin Afirka da aka karɓa.

Yawancin Indiyawan an yi musu allurar rigakafin ta Indiya AstraZeneca Shots, wanda Cibiyar Serum ta Indiya ta samar. Wasu kuma sun sami maganin COVAXIN, allurar da wani kamfanin Indiya ya samar wanda ba a amfani da shi a Biritaniya.

Ƙin amincewa da Burtaniya ta karɓi wasu takaddun shaida na allurar rigakafi ya haifar da fargaba kan cewa hakan na iya haifar da jinkirin rigakafin.

Kasashen da suka karɓi ɗaruruwan dubunnan allurai na allurar AstraZeneca daga gwamnatin Biritaniya an bar su suna mamakin me yasa shirye -shiryen rigakafin su bai isa ba a idanun mai bayar da maganin.